Provided by Tiger Fintech (Singapore) Pte. Ltd.

I-MAB

3.62
-0.1050-2.82%
Volume:765.05K
Turnover:2.76M
Market Cap:415.70M
PE:-7.97
High:3.81
Open:3.60
Low:3.52
Close:3.72
52wk High:5.90
52wk Low:0.5950
Shares:114.99M
Float Shares:48.23M
Volume Ratio:0.59
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4537
EPS(LYR):-0.2738
ROE:-17.08%
ROA:-10.36%
PB:2.11
PE(LYR):-13.20

Loading ...

I-Mab Unveils Corporate Presentation Highlighting Advancements in Givastomig for Gastric Cancer and Strategic Growth Initiatives

Reuters
·
Jun 02

I-Mab to Present at Jefferies Global Healthcare Conference

GlobeNewswire
·
May 20

I-Mab reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16

BRIEF-I-Mab Reports First Quarter 2025 Financial Results

Reuters
·
May 15

I-Mab Reported Q1 Net Loss Per ADS Of $(0.04), Cash Balance Of $168.6M

Benzinga
·
May 15

I-Mab Reports Strong Financial Position with $168.6M Cash and Investments, Interest Income Rises in Q1 2025

Reuters
·
May 15

Press Release: I-Mab Reports First Quarter 2025 Financial Results and Provides Business Update

Dow Jones
·
May 15

BRIEF-I-Mab Announces Givastomig Abstract Accepted For Oral Presentation At ESMO GI 2025

Reuters
·
Apr 30

I-Mab Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 04

I-Mab expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
Apr 04

BRIEF-I-Mab Reports Full Year 2024 Financial Results

Reuters
·
Apr 04

I-MAB FY24 Adj EPADS $(0.27) Up From $(2.50) YoY

Benzinga
·
Apr 04

Press Release: I-Mab Reports Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
Apr 04

I-Mab expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
Mar 31

I-Mab Gets Nasdaq Noncompliance Notice on Bid Price Requirement

MT Newswires Live
·
Mar 22

BRIEF-I-Mab gets Nasdaq notice regarding minimum bid price requirement

Reuters
·
Mar 22

I-Mab expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
Mar 21